Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Methylene Blue
Therapeutic Area : Hematology
Study Phase : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Nexus Pharmaceuticals Receives FDA Approval for Methylene Blue Injection, USP
Details : The US FDA approved Methylene Blue Injection, USP (methylene blue). It is an oxidation-reduction agent that offers treatment of acquired methemoglobinemia.
Brand Name : Methylene Blue Injection, USP
Molecule Type : Small molecule
Upfront Cash : Not Applicable
November 26, 2024
Lead Product(s) : Methylene Blue
Therapeutic Area : Hematology
Highest Development Status : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Lead Product(s) : Methylene Blue,Chlorhexidine Gluconate
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Healthcare's Memorial Health University Medical Center
Deal Size : Not Applicable
Deal Type : Not Applicable
Ondine Biomedical Completes Patient Recruitment for US Phase II Nasal Photodisinfection Trial
Details : Photodynamic Antimicrobial Chemotherapy (PACT) using methylene blue is a potential antimicrobial therapy that combines light and a photosensitizing drug, promoting a phototoxic effect on the treated cells increases membrane permeability in Candida albica...
Brand Name : PACT
Molecule Type : Small molecule
Upfront Cash : Not Applicable
August 08, 2022
Lead Product(s) : Methylene Blue,Chlorhexidine Gluconate
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Healthcare's Memorial Health University Medical Center
Deal Size : Not Applicable
Deal Type : Not Applicable
Lead Product(s) : Methylene Blue
Therapeutic Area : Hematology
Study Phase : Approved
Sponsor : Provepharm Life Solutions
Deal Size : Not Applicable
Deal Type : Not Applicable
American Regent Launches a New Vial Presentation
Details : ProvayBlue (methylene blue) is hypotonic and may be diluted before use in a solution of 50 mL 5% Dextrose Injection in order to avoid local pain, particularly in the pediatric population. Use the diluted solution immediately after preparation.
Brand Name : ProvayBlue
Molecule Type : Small molecule
Upfront Cash : Not Applicable
June 30, 2022
Lead Product(s) : Methylene Blue
Therapeutic Area : Hematology
Highest Development Status : Approved
Sponsor : Provepharm Life Solutions
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?